MSF's Suerie Moon spoke in front of a US Senate Committee on promoting new treatments & cures for neglected diseases read more
NEW: The 13th Edition of Untangling the Web of Antiretroviral Price Reductions is now available download it here
VIDEO: MSF's community approach to treating malnutrition in Niger watch it here
WHO's work on the financing of medical research and development is given a fresh start read more
MSF Letter to GFATM on concerns over scale-up of AIDS treatment in light of Board of Directors Meeting read more
New European Parliament Working Group on Innovation & Access launches with support of Access Campaign read more
|
 |
|
 |
The ‘Make It Happen’ campaign is calling on pharmaceutical companies to put their HIV drug patents in the UNITAID patent pool. The pool could mean that people in developing countries can get the life-saving antiretroviral medicines they need.
On World AIDS Day, we are asking ten drug companies to listen to the millions without access to adequate AIDS treatment. We’ll be turning up the volume:
PUT YOUR HIV DRUG PATENTS IN THE POOL !!!!!!!!!
And we are making it happen
All drug companies are now in discussion with UNITAID about the creation of the patent pool – largely because of our campaign. So thanks to you for your support.
All bar one of the ten drug companies have contacted MSF directly in response to the campaign. All of them have said that they are interested in discussing the pool with UNITAID. A number have been very positive:
Since we launched our campaign in September, nearly 115,000 mails have been sent to drug companies in support of the pool, calling on them to: MAKE IT HAPPEN.
Quote of the Week
"We believe if structured appropriately, UNITAID's patent pool can play a critical role in expanding access to antiretroviral treatment for patients around the world by encouraging the development of new fixed-dose combinations and paediatric formulations, lowering prices, while respecting intellectual property."
-- Gregg Alton, Senior Vice President, Gilead Sciences
But the devil is in the details and one of the key issues that has emerged is which countries should benefit from medicines made under licence from the pool.
All developing countries must be included in the pool
One thing needs to be made crystal clear. A patent pool should benefit all people living with HIV in developing countries. Some drug companies want to divide countries up and exclude patients in Brazil, India, South Africa and China, for example. The majority of the population in these countries still live in poverty and need access to cheaper HIV drugs and newer drug combinations that the pool could provide. More importantly, it is precisely in these countries that the expertise and experience in producing affordable generic drugs is to be found. These countries cannot be shut out of the patent pool initiative. UNITAID’s starting point is to include all developing countries. They need to stand firm on this principle. All developing countries need to be beneficiaries of the pool.
It’s a global thing…
We’ve got supporters all around the world. And apart from the online action, we’ve been getting signatures from patient groups in developing countries, from South Africa, Liberia and the Democratic Republic of Congo.
A Make It Happen platform has also been launched in Brazil.
FATAL FLAWS: How Kenya's 2008 Anti-Counterfeit Act could endanger access to medicines 
Presenation: Missing ARVs for HIV/AIDS treatment in 2009 - Unitaid Patent Pool Briefing
HIV/AIDS treatment in developing countries: the battle for long-term survival has just begun
